The Cooper Companies, Inc. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $4.1B |
| Gross margin | 65.5% |
| Operating income | $682.9M |
| Net income | $374.9M |
| Diluted EPS | $1.87 |
| Cash & equivalents | $110.6M |
| Total assets | $12.4B |
| Long-term debt | $2.5B |
Key takeaway
Cooper Companies reported fiscal 2025 revenue of $4.09 billion with a 65.5% gross margin, driven by its CooperVision contact lens and CooperSurgical fertility/women's health segments.
🔒 4 more takeaways in the full analysis
Beneath the surface
Cash of only $110.6 million against total debt of $2.505 billion (DebtLongtermAndShorttermCombinedAmount) leaves Cooper in a net debt position of roughly $2.39 billion, a materially different picture than the headline cash figure alone suggests.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for COO.
Read the full analysis free Free account · 5 full analyses included · no card required